"Timolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A beta-adrenergic antagonist similar in action to PROPRANOLOL. The levo-isomer is the more active. Timolol has been proposed as an antihypertensive, antiarrhythmic, antiangina, and antiglaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.
Descriptor ID |
D013999
|
MeSH Number(s) |
D02.033.100.624.915 D02.033.755.624.915 D02.092.063.624.915 D02.886.675.867.768 D03.383.129.708.867.768 D03.383.533.640.775
|
Concept/Terms |
Timolol- Timolol
- (S)-1-((1,1-Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadazol-3-yl)oxy)-2-propanol
- Timolol Hemihydrate
- Hemihydrate, Timolol
|
Below are MeSH descriptors whose meaning is more general than "Timolol".
Below are MeSH descriptors whose meaning is more specific than "Timolol".
This graph shows the total number of publications written about "Timolol" by people in this website by year, and whether "Timolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Timolol" by people in Profiles.
-
Giorgio CMR, Licata G, Briatico G, Babino G, Fulgione E, Gambardella A, Alfano R, Argenziano G. Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma. Int J Dermatol. 2021 May; 60(5):631-633.
-
Ross A, Blake RC, Ayyala RS. Surface tension of aqueous humor. J Glaucoma. 2010 Sep; 19(7):456-9.
-
Coleman AL, Lerner F, Bernstein P, Whitcup SM. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension. Ophthalmology. 2003 Dec; 110(12):2362-8.